Ropes & Gray has advised Brookfield on the deal. Brookfield, through its real estate solutions strategy, alongside Copley Point Capital, a specialist manager and operator of...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sarepta Therapeutics on the deal. Sarepta Therapeutics, Inc. announced separate, privately negotiated exchange agreements with certain holders of its 1.50% Convertible Senior...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Gauge Capital on the deal. Gauge Capital announced its investment in Streamline Healthcare Solutions, a provider of electronic health record (“EHR”) software primarily...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Matrix on the deal. Matrix – a market-leading workforce technology and services platform, and portfolio company of Bridgepoint Development Capital –...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Provention Bio, Inc. on the deal. Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced a sales agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Bridgepoint on the deal. Bridgepoint (BDC IV), a fund focused on investing in mid-market growth businesses, announced its partnership with Monica Vinader,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advises AEA Investors on the deal. AEA Investors announced its sale of LoneStar to Epiris, a private equity firm. LoneStar is a UK-headquartered...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised LianBio on the deal. Pfizer and LianBio announced on December 19, 2022 that Pfizer has opted in to the right to develop...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton LLP and Ropes & Gray LLP advised Gentiva, while BakerHostetler advised ProMedica. Gentiva, a dedicated hospice, palliative, and personal care company driving improved...
You must be a Standard 1 Year member to access this content.
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Davis Polk advised K&N Engineering Inc., Ropes & Gray advised an ad hoc group of first lien lenders, Crowell & Moring advised the revolving first lien...
You must be a Standard 1 Year member to access this content.
